Los Angeles Capital Management LLC Tarsus Pharmaceuticals, Inc. Transaction History
Los Angeles Capital Management LLC
- $28.5 Billion
- Q3 2025
A detailed history of Los Angeles Capital Management LLC transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 37,102 shares of TARS stock, worth $2.62 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
37,102
Previous 23,533
57.66%
Holding current value
$2.62 Million
Previous $953,000
131.27%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TARS
# of Institutions
216Shares Held
46.9MCall Options Held
7.8KPut Options Held
0-
Black Rock Inc. New York, NY3.27MShares$230 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.11MShares$219 Million1.94% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.98MShares$210 Million5.63% of portfolio
-
Jennison Associates LLC2.6MShares$184 Million0.09% of portfolio
-
Tang Capital Management LLC San Diego, CA2.45MShares$173 Million5.96% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.88B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...